JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1988; 67:99-106
© 1988 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anger, C.
Right arrow Articles by Prys-Roberts, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anger, C.
Right arrow Articles by Prys-Roberts, C.

Antihypertensive Mechanism of Ketanserin in Postoperative Hypertension After Cardiopulmonary Bypass

Christian Anger, MD, John A. Carter, MB, BS, FFARCS, and Cedric Prys-Roberts, DM, PhD, FFARCS

the Sir Humphry Davy Department of Anaesthesia, University of Bristol, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom.

Abstract

The effect of ketanserin (0.15 mg/kg followed by an infusion at 6 mg/hr) was studied in 13 patients who developed hypertension (blood pressure > 150/90 mm Hg) after cardiopulmonary bypass (CPB) for coronary artery bypass grafting. Eleven patients responded to ketanserin with a decrease of arterial pressure from 159 ± 15/83 ± 10 mm Hg to 131 ± 9/70 ± 12 mm Hg (P < 0.01), which was sustained during the subsequent infusion of ketanserin. Mean plasma ketanserin concentrations were maintained at 187 /µg/L (range 118–525). No significant changes in plasma levels of 5-hydroxyindoles or in platelet 5-hydroxytryptamine content were observed during or after CPB, or after administration of ketanserin. Plasma epinephrine (398 ± 124 pg/ml) and norepinephrine (1161 ± 673 pg/ml) concentrations were markedly increased during the hypertensive period after CPB. Plasma epincphrine concentrations decreased (P < 0.01) during ketanserin infusion to 213 ± 101 pg/ml, whereas plasma norepinephrine concentrations did not change. The pressor response to three graded doses of phenylephrine was decreased during CPB (P < 0.01), and a further decrease (P < 0.05) occurred during infusion of ketanserin. The hypotensive effect of ketanserin after CPB may be attributable to alpha1,-adrenoceptor blockade rather than to its antiserotoninergic effect. Serotonin does not appear to be involved in the short-term disturbances of arterial pressure during or after CPB.

Key Words: SEROTONIN–-ketanserin. • PHARMACOLOGY–-ketanserin. • ANESTHESIA • CARDIOVASCULAR–-ketanserin.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1988 by the International Anesthesia Research Society.